Latest news
-
Scott Bardo is returning to the fold after 10 years with Berenberg -
German pharmaceuticals platform breaks the ice for large cap listings in Europe this year
-
It could take years to develop a gene therapy to slow aging, but much less for big pharma to scoop up Genflow Biosciences
-
PRA to return to risk-weighted asset-based calculation for Pillar 2A
-
The pandemic has helped the Swiss online pharmacy to boost its business
-
Emerging markets reliant upon tourism find relief
-
German medical company is working towards reinclusion in the SDax
-
Emerging markets have come under pressure this week, but some could fare worse than others
-
Last minute issuance will be focused on safe-haven products
